clinical 1,096 words KG: ent-gene-694200ea
Contents

GBA Brain Molecular Imaging and Blood Biomarkers for Precision Medicine in PD (NCT06167603)

🔬 Protein Info
Gene Symbolent-gene-694200ea
Metabolic patternsDetects regional cerebral glucose metabolism changes characteristic of PD and GBA-PD subtypes
Network analysisIdentifies patterns such as the PD-related spatial covariance pattern (PDRP) that may differ between GBA-PD and iPD
Individual assessmentEnables subject-level metabolic profiling beyond group averages
KG Connections4 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (10)

Purinergic Signaling Polarization Control
Score: 0.71
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Lysosomal Positioning Dynamics Modulation
Score: 0.69
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
Lysosomal Membrane Repair Enhancement
Score: 0.54
Blood-Brain Barrier SPM Shuttle System
Score: 0.53
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51

Related Analyses (18)

Astrocyte Reactivity Subtypes in Neurodegeneration
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (15)

Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40
Genetic Risk Modifiers in DLB Phenotype
clinical · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40
DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · completed · Score: 0.40

See Also (15)

Alpha-Synuclein PET Imaging and Biomarker Advances
biomarker · Pages share 3 hypotheses
Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)
biomarker · Pages share 3 hypotheses
Blood-Based Biomarkers for Neurodegeneration
biomarker · Pages share 3 hypotheses
Blood p-Tau181 and p-Tau217 Elevated in Systemic Amyloi
biomarker · Pages share 3 hypotheses
CSF Biomarkers for Corticobasal Syndrome and Progressiv
biomarker · Pages share 3 hypotheses

Knowledge Graph (4 edges)

ent-gene-694200ea data_in benchmark_ot_ad_answer_key:GBA
benchmark_ot_ad_answer_key:GBA data_in ent-gene-694200ea
ent-gene-694200ea participates_in_pathway R-HSA-9840310
ent-gene-694200ea participates_in_pathway R-HSA-390471

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.